Breaks Categories: News

TuesdayFeb 13, 2024 1:29 pm

NetworkNewsBreaks – WestPark Capital Reiterates Buy Rating on D-Wave Quantum Inc. (NYSE: QBTS), Recaps Analyst Day Visit

WestPark Capital recently published its recap of the recent analyst day event hosted by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software and services. Highlights of the visit included discussions by several customers about the benefits they are experiencing by using D-Wave’s solutions, anticipation for the launch of the company’s next-generation quantum processor, additional opportunities in government, and a growing number of use cases that have the potential to expand the size of the market opportunity for D-Wave to $100 billion by 2030. A key excerpt of the report reads,…

Continue Reading

TuesdayFeb 13, 2024 1:10 pm

NetworkNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Releases Q2 2024 Financial Report

Astrotech (NASDAQ: ASTC), an innovative science and technology company, is releasing its financial results for Q2 2024, the period ended Dec. 31, 2023. Highlights of the report include a 512% increase in year-to-date revenue, which reached $1,540,000 compared to $301,000 in the same period in 2023; a strong consolidated balance sheet with $37 million in cash and liquid investments; and a year-to-date FY 2024 gross margin increase of 46% from 38% during the same period in 2023. In addition, the company reported that its 1st Detect subsidiary reentered detection and nondetection testing with the U.S. Transportation Security Administration (“TSA”) for cargo…

Continue Reading

TuesdayFeb 13, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Engages Global CRO to Support NDA Submission for Approval of Tonmya(TM) for Fibromyalgia Management

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has engaged Rho, Inc., a global contract research organization (“CRO”). Under the terms of the engagement, Rho will support Tonix in preparing its New Drug Application (“NDA”) for planned submission to the U.S. Food and Drug Administration (“FDA”) for the clearance of Tonmya(TM), a patented sublingual tablet formulation of cyclobenzaprine hydrochloride, for the management of fibromyalgia. “We are excited by our most recent positive Phase 3 study results of Tonmya and look forward to Rho’s support in preparing our NDA,” said Seth Lederman,…

Continue Reading

MondayFeb 12, 2024 1:50 pm

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Makes ‘First Major Move’ into Retail Market

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has been accepted as a vendor for all Ace Hardware stores, which form a network comprising over 4,500 locations. According to the announcement, all Ace Hardware stores will be able to order directly from SenesTech, and the company will participate in Ace Hardware’s vendor events, including the Ace semi-yearly markets. “We are excited to be working with Ace Hardware. They represent leaders in the retail market for do-it-yourselfers and the consumer market, for which our Evolve(TM) soft bait is uniquely positioned,” said SenesTech’s President and CEO Joel…

Continue Reading

MondayFeb 12, 2024 1:42 pm

NetworkNewsBreaks – Bravo Multinational, Inc. (BRVO) Solidifies Entry into Dynamic World of Streaming

Bravo (OTC: BRVO) recently announced it has entered into an agreement to acquire the assets of Streaming TVEE, Inc., which stands at the forefront of licensed streaming technology. The agreement, the announcement states, solidifies Bravo’s entry into streaming and establishes the business foundation for its previously announced flagship offering, TVee NOW(TM), a new streaming service slated for Beta launch in Q1 2024. TVee NOW(TM) will be available directly to consumers via the web on any connected TV (“CTV”), smartphone or tablet and intends to offer traditional broadcast TV, which encompasses cable and satellite networks through a joint venture with Pythia…

Continue Reading

MondayFeb 12, 2024 1:31 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reinforces Position as Market Leader with Announcement of New EM Contract in California

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has secured a new contract with an established California services provider in the judicial sector. According to the announcement, the contract is already operational and generating revenue; it also has long-term growth potential. SuperCom was awarded the contract over a long-time incumbent competitor, a reflection of the potential for the company’s new PureOne solution as well as its vision of expanding its footprint in the U.S. market and the competitive edge provided by delivering superior technology solutions. “We are pleased to announce a…

Continue Reading

MondayFeb 12, 2024 11:45 am

NetworkNewsBreaks — Upstream Offers Solutions to Hurdles for International Investors, Launches Exchange Dual Listing Program

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, is working to create economic development for foreign exchanges and their issuers. As part of that focus, the company has announced its Exchange Dual Listing Program for 2024. “As it stands today, it is difficult for international investors to buy U.S.- and Canadian-listed securities,” a recent Upstream article stated. “Retail investors outside the U.S. and Canada don’t typically have streamlined access to purchase NASDAQ, NYSE, OTC, TSX, TSX.V, CSE or shares from smaller exchanges around the world without going through a cumbersome…

Continue Reading

MondayFeb 12, 2024 10:57 am

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Closes on Nonbrokered Private Placement

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has closed on the final tranche of its nonbrokered private placement. As part of the transaction, the company issued 9,961,909 units at $0.055 per unit, with a unit comprising one common share and one common share purchase warrant; the warrant allows holders to purchase an additional common share at $0.07 until Feb. 9, 2029. Gross proceeds for the placement totaled $547,905. “When combined with the first tranche of the offering, the company has raised gross proceeds of $1,897,905 through the issuance…

Continue Reading

MondayFeb 12, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives FDA IND Approval for Phase 2 OASIS Trial of TNX-102 SL in Acute Trauma Patients

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that it has received approval from the U.S. Food and Drug Administration (“FDA”) for the Investigational New Drug (“IND”) application for the investigator-initiated OASIS trial. The OASIS trial is a Phase 2 trial to evaluate TNX-102 SL in reducing the severity of acute stress reaction (“ASR”) and the frequency of acute stress disorder (“ASD”) and posttraumatic stress disorder (“PTSD”). The trial will enroll approximately 180 acute trauma patients following motor vehicle collisions. It is sponsored by The University of North Carolina…

Continue Reading

FridayFeb 09, 2024 3:07 pm

NetworkNewsBreaks — Immix Biopharma Inc. (NASDAQ: IMMX) Closes on $15M Public Offering

Immix Biopharma (NASDAQ: IMMX), a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, has closed on its previously announced underwritten public offering. The offering consisted of 5,535,055 shares of IMMX common stock, with each share sold at $2.71 per share. Gross proceeds from the offering to ImmixBio are projected to be an estimated $15 million, before standard deductions and expenses. According to the announcement, ImmixBio plans to use funds from the offering for its NXC-201 clinical trials as well as working capital and general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as sole…

Continue Reading